Panelists discuss how hidradenitis suppurativa poses significant diagnostic and treatment challenges, while exploring current management approaches, emerging therapies, dosing considerations, and the potential of AI technology to improve early detection and patient outcomes.
Treatment Switches and the Future of Hidradenitis Suppurativa Management
December 5th 2024Panelists discuss how identifying optimal timing for treatment switches and emerging therapeutic innovations are reshaping the management landscape for hidradenitis suppurativa, with the potential to improve long-term patient outcomes.
Setting Patient Expectations and Use of Combination Treatment for Hidradenitis Suppurativa
December 5th 2024Panelists discuss how managing patient expectations while implementing combination treatment approaches can optimize outcomes in hidradenitis suppurativa, emphasizing the importance of clear communication about treatment goals and timelines.